BELLUS Health Inc

(NASDAQ:BLU)

Latest On BELLUS Health Inc (BLU):

Date/Time Type Description Signal Details
2023-05-12 21:12 ESTNewsBELLUS Health GAAP EPS of -$0.20, revenue of $3KN/A
2023-04-18 21:06 ESTNewsHot Stocks: BLU rises on buy out offer from GSK; ERIC slips on earnings; NVDA, GMDA gains; MP slidesN/A
2023-04-18 07:53 ESTNewsBellus surges ~100% after GSK reaches deal to acquire cough drugmaker for ~$2BN/A
2023-04-05 19:47 ESTNewsBellus Health posts proof-of-concept data for cough candidateN/A
2023-03-21 17:24 ESTNewsBELLUS Health GAAP EPS of -$0.66 beats by $0.07, revenue of $16MN/A
2022-12-23 21:40 ESTNewsBellus Health: Building Momentum Around CALM, SOOTHE StudiesN/A
2022-11-15 16:10 ESTNewsBELLUS Health GAAP EPS of -$0.20 misses by $0.03N/A
2022-09-07 15:10 ESTNewsBellus: Expected Phase 3 Start Makes This A Long-Term PlayN/A
2022-08-11 06:49 ESTNewsBELLUS Health GAAP EPS of -$0.18 misses by $0.01, revenue of $0.04M beats by $0.04MN/A
2022-07-14 03:42 ESTNewsRBC Capital Markets reiterates outperform rating, ups price target on BELLUS HealthN/A
2022-07-14 03:42 ESTNewsBELLUS Health announces launch of public offering of shares in Canada, U.S.N/A
2022-07-14 03:42 ESTNewsBELLUS Health slides on pricing $153M stock offering in Canada, U.S.N/A
2022-07-12 23:35 ESTNewsBELLUS details late-stage plans for cough candidate after FDA meetingN/A
2022-05-11 20:17 ESTNewsBELLUS Health GAAP EPS of -$0.13 beats by $0.06, revenue of $4MN/A
2022-02-24 09:30 ESTNewsBELLUS Health GAAP EPS of -$0.90 beats by $0.01, revenue of $16KN/A
2022-01-26 02:36 ESTNewsMerck’s setback for cough candidate bodes well for BELLUS - H.C. WainwrightN/A
2021-12-15 06:54 ESTNewsBellus Health prices $200M of stock offeringN/A
2021-12-14 10:59 ESTNewsBELLUS Proof Of Data In Chronic Cough Using BLU-5937 Brings Hope To PatientsN/A
2021-12-13 16:19 ESTNewsBellus Health jumps 33% on positive BLU-5937 data in mid-stage chronic cough studyN/A
2021-12-13 16:17 ESTNewsBELLUS Health to launch its $175M stock offering in U.S. and CanadaN/A
2021-11-11 02:19 ESTNewsBELLUS Health EPS misses by $0.06N/A
2021-09-24 00:07 ESTNewsBELLUS Health completes enrollment in mid-stage BLU-5937 and BLU-5937 trialsN/A
2021-09-19 04:23 ESTNewsBELLUS Health (BLU ) Investor Presentation - SlideshowN/A
2021-09-17 15:04 ESTNewsBELLUS gains on positive interim findings from trial for patients with chronic coughN/A
2021-09-17 15:00 ESTNewsBELLUS gains continue for second day following chronic cough data resultsN/A
2021-08-27 05:17 ESTNewsBellus Health - Betting Big On Chronic Cough TreatmentN/A
2021-07-29 14:56 ESTNewsBellus Health initiated with a buy at BTIG on potential of lead candidate; shares up 5%N/A
2021-02-27 23:14 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 20:51 ESTNewsBELLUS Health EPS misses by $0.01N/A
2021-01-02 15:16 ESTFinancialsCompany financials have been released.Neutral
2020-12-24 03:03 ESTNewsBELLUS Health establishes $50M at-the-market facilityN/A
2020-12-14 15:40 ESTNewsDosing underway in BELLUS Health's mid-stage atopic dermatitis study with BLU-5937N/A
2020-12-13 03:22 ESTFinancialsCompany financials have been released.Neutral
2020-12-08 21:00 ESTNewsDosing underway in mid-stage study of BELLUS Health's BLU-5937 in chronic coughN/A
2020-12-07 23:17 ESTNewsBELLUS Health names Ramzi Benamar as CFON/A
2020-11-19 12:31 ESTNewsHuge bull call on BELLUS Health from Evercore implies +400% upsideN/A
2020-11-17 03:20 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 18:35 ESTNewsBELLUS Health EPS beats by $0.05N/A
2020-11-01 17:20 ESTFinancialsCompany financials have been released.Neutral
2020-10-24 18:49 ESTNewsBELLUS Health up 9.8% on Point72 stake disclosureN/A
2020-10-19 16:27 ESTNewsBellus Health under pressure on planned equity offeringN/A
2020-09-24 00:16 ESTFinancialsCompany financials have been released.Neutral
2020-09-16 14:08 ESTNewsBELLUS Health Inc (BLU) Investor Presentation - SlideshowN/A
2020-08-18 16:16 ESTFinancialsCompany financials have been released.Neutral
2020-08-17 16:16 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 12:46 ESTNewsBELLUS Health EPS beats by $0.04N/A
2020-08-06 20:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 00:22 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 12:19 ESTFinancialsCompany financials have been released.Neutral

About BELLUS Health Inc (BLU):

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.

BLU Quotes by TradingView

See Advanced Chart

General

  • Name BELLUS Health Inc
  • Symbol BLU
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 32
  • Last Split Factor277:1000
  • Last Split Date2019-08-19
  • Fiscal Year EndDecember
  • IPO Date2008-12-29
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.bellushealth.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 16801.99
  • Price/Book (Most Recent Quarter) 2.27
  • Enterprise Value Revenue 15599.14
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Operating Margin -219613%
  • Return on Assets -17%
  • Return on Equity -27%
  • Revenue 15000
  • Earnings Per Share -$0.51
  • Revenue Per Share $0
  • Gross Profit 15000
  • Quarterly Earnings Growth -42.9%
View More

Highlights

  • Market Capitalization 315.43 million
View More

Share Statistics

  • Shares Outstanding 78.34 million
  • Shares Float 41.88 million
  • % Held by Insiders 2195%
  • % Held by Institutions 47.48%
  • Shares Short 2.15 million
  • Shares Short Prior Month 1.14 million
  • Short Ratio 1.04
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta -0.33
  • 52 Week High $12.03
  • 52 Week Low $2.12
  • 50 Day Moving Average 3.91
  • 200 Day Moving Average 3.05
View More

Dividends

  • Dividend Date 2019-08-19
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

BELLUS Health Inc (BLU) Dividend Calendar:

BLU's last dividend payment was made to shareholders on August 19, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

BELLUS Health Inc (BLU) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A-$0.11-$0.1316.77%
2020-09-302020-11-12$3000-$0.09-$0.1434.26%
2020-06-302020-08-13$N/A-$0.14-$0.1821.32%
2020-03-312020-05-14$4000-$0.18-$0.16-11.55%
2019-12-312020-02-27$9000-$0.19-$0.11-71.78%
2019-09-302019-11-14$9000-$0.14-$0.1717.93%
2019-06-302019-08-08$8000-$0.14-$0.07-98.98%
2019-03-312019-05-08$9000-$0.08-$0.03-192.34%
2018-12-312019-02-21$9000-$0.07-$0.05-32.77%
2018-09-302018-11-14$9000-$0.07-$0.06-21.52%
2018-06-302018-08-08-$0.04-$0.0526.96%
2018-03-312018-05-15-$0.06-$0.03-97.88%
2017-12-312018-02-21-$0.06-$0.06-0.69%
2017-09-302017-11-08-$0.08
2017-06-302017-08-09$0.01
2017-03-312017-05-11$0.05
2016-12-312017-02-28-$0.02
2016-09-302016-11-10-$0.03
2016-06-302016-08-09-$0.03-$0.0651.25%
2016-03-312016-05-12-$0.03-$0.03-1.08%
2015-12-312016-02-24$0.05-$0.01504.58%
2015-09-302015-11-12-$0.01
2015-06-302015-08-12-$0.03
2015-03-312015-05-12$-0.00
2014-12-312015-02-25$0.01
2014-09-302014-11-05-$0.05
2014-06-302014-08-13-$0.05
2014-03-312014-05-08-$0.05
2013-12-312014-02-26-$0.04
2013-09-302013-11-06$0.07
2013-06-302013-08-07-$0.06
2013-03-312013-05-16-$0.04
2012-12-312013-02-27-$0.04
2012-09-302012-11-08-$0.02
2012-06-302012-08-08-$1.37
2012-03-312012-05-15-$1.20
2011-12-312012-02-23-$0.08
2011-09-302011-11-09-$0.22
2011-06-302011-08-08-$0.14
2011-03-312011-05-11-$0.27
2010-12-312011-02-23-$1.93
2010-09-302010-11-10-$3.09
2010-06-302010-08-09-$2.91
2010-03-312010-05-12-$2.09
2009-12-312010-02-25-$3.24
2009-09-302009-11-11-$3.81
2009-06-302009-08-12-$3.12
2009-03-312009-05-06-$21.32
2008-12-312009-02-26-$24.84-$22.68-9.52%
2008-09-302008-11-10-$23.76-$19.44-22.22%
2008-06-302008-08-05-$28.08-$20.52-36.84%
2008-03-312008-05-05-$28.08-$25.92-8.33%
2007-12-312008-02-20-$35.64-$22.68-57.14%
2007-09-302007-11-07-$31.32-$43.0327.21%
2007-06-302007-08-09-$81.00-$53.01-52.8%
2007-03-312007-05-08-$58.32-$47.73-22.19%
2006-12-312007-02-21-$47.52-$44.67-6.38%
2006-09-302006-11-08-$46.44-$43.13-7.67%
2006-06-302006-08-09-$50.76-$45.35-11.93%
2006-03-312006-05-09-$42.12-$44.044.36%
2005-12-312006-02-23-$38.88-$49.6821.74%
2005-09-302005-11-08-$51.84-$42.84-21.01%
2005-06-302005-08-10-$46.44-$44.40-4.59%
2005-03-312005-05-12-$46.44-$44.02-5.5%
2004-12-312005-02-22-$45.36-$37.08-22.33%
2004-09-302004-11-04-$37.80-$52.9228.57%
2004-06-302004-08-17-$38.83-$34.99-10.97%
2004-03-312004-05-11-$24.20-$23.28-3.95%
2003-12-312004-02-23-$11.28-$17.6636.13%
2003-09-302003-11-12-$20.57-$17.28-19.04%
2003-06-302003-08-18-$23.88-$21.02-13.61%
2003-03-312003-05-14-$15.52-$20.1823.09%

BELLUS Health Inc (BLU) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

BELLUS Health Inc (BLU) Chart:

BELLUS Health Inc (BLU) News:

Below you will find a list of latest news for BELLUS Health Inc (BLU) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

BELLUS Health Inc (BLU) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest BLU Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$7.76
Jun 13, 2022 7:59 PM EST800$7.76
Jun 13, 2022 7:59 PM EST100$7.76
Jun 13, 2022 7:59 PM EST2$7.76
Jun 13, 2022 7:59 PM EST22$7.76

BELLUS Health Inc (BLU) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1259942/000094787120000554/0000947871-20-000554-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1259942/000031506620000855/0000315066-20-000855-index.htm
2020-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1259942/000089534520000035/0000895345-20-000035-index.htm
2020-10-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1259942/000089914020000487/0000899140-20-000487-index.htm
2019-09-18SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1259942/000094787119000690/0000947871-19-000690-index.htm
2020-06-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1259942/000094787120000554/0000947871-20-000554-index.htm
2020-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1259942/000094787120000805/0000947871-20-000805-index.htm
2009-06-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1259942/000095012309011669/0000950123-09-011669-index.htm
2009-06-29SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1259942/000095012309018643/0000950123-09-018643-index.htm
2009-07-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1259942/000095012309021181/0000950123-09-021181-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1259942/000095014220000387/0000950142-20-000387-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000110465919064113/0001104659-19-064113-index.htm
2019-12-20F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1259942/000110465919074962/0001104659-19-074962-index.htm
2019-12-20F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1259942/000110465919075023/0001104659-19-075023-index.htm
2020-01-17F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1259942/000110465920005127/0001104659-20-005127-index.htm
2020-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1259942/000110465920011938/0001104659-20-011938-index.htm
2020-02-2740-FRegistration statement [Section 12] or Annual Report [Section 13(a), 15(d)]https://www.sec.gov/Archives/edgar/data/1259942/000110465920026291/0001104659-20-026291-index.htm
2020-03-23SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1259942/000110465920037064/0001104659-20-037064-index.htm
2020-03-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000110465920037088/0001104659-20-037088-index.htm
2020-04-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000110465920044004/0001104659-20-044004-index.htm
2020-04-21S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1259942/000110465920049294/0001104659-20-049294-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000110465920061708/0001104659-20-061708-index.htm
2020-05-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1259942/000110465920061727/0001104659-20-061727-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000110465920094650/0001104659-20-094650-index.htm
2020-10-19SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1259942/000110465920116130/0001104659-20-116130-index.htm
2020-10-20SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1259942/000110465920116449/0001104659-20-116449-index.htm
2020-10-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000110465920116459/0001104659-20-116459-index.htm
2019-09-03F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1259942/000114420419043097/0001144204-19-043097-index.htm
2019-09-03F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1259942/000114420419043103/0001144204-19-043103-index.htm
2019-09-038-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1259942/000114420419043106/0001144204-19-043106-index.htm
2019-09-04F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1259942/000114420419043428/0001144204-19-043428-index.htm
2019-09-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000114420419043506/0001144204-19-043506-index.htm
2019-09-05SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1259942/000114420419043567/0001144204-19-043567-index.htm
2019-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000114420419043877/0001144204-19-043877-index.htm
2019-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000114420419044841/0001144204-19-044841-index.htm
2019-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000114420419044904/0001144204-19-044904-index.htm
2019-09-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1259942/000114420419045836/0001144204-19-045836-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752319002257/0001157523-19-002257-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752319002266/0001157523-19-002266-index.htm
2020-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000235/0001157523-20-000235-index.htm
2020-02-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000283/0001157523-20-000283-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000378/0001157523-20-000378-index.htm
2020-03-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000417/0001157523-20-000417-index.htm
2020-04-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000473/0001157523-20-000473-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000667/0001157523-20-000667-index.htm
2020-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000670/0001157523-20-000670-index.htm
2020-05-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000737/0001157523-20-000737-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000747/0001157523-20-000747-index.htm
2020-05-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000818/0001157523-20-000818-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320000956/0001157523-20-000956-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320001179/0001157523-20-001179-index.htm
2020-09-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320001228/0001157523-20-001228-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320001234/0001157523-20-001234-index.htm
2020-10-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000115752320001322/0001157523-20-001322-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1259942/000117266120000499/0001172661-20-000499-index.htm
2020-03-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000117625620000063/0001176256-20-000063-index.htm
2020-04-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000117625620000126/0001176256-20-000126-index.htm
2009-03-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000064/0001206212-09-000064-index.htm
2009-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000068/0001206212-09-000068-index.htm
2009-04-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1259942/000120621209000070/0001206212-09-000070-index.htm
2009-04-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000072/0001206212-09-000072-index.htm
2009-04-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000075/0001206212-09-000075-index.htm
2009-04-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1259942/000120621209000082/0001206212-09-000082-index.htm
2009-04-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000088/0001206212-09-000088-index.htm
2009-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000092/0001206212-09-000092-index.htm
2009-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000103/0001206212-09-000103-index.htm
2009-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000108/0001206212-09-000108-index.htm
2009-05-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000110/0001206212-09-000110-index.htm
2009-05-11F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1259942/000120621209000113/0001206212-09-000113-index.htm
2009-05-11F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1259942/000120621209000114/0001206212-09-000114-index.htm
2009-05-1215-12GSecurities registration termination [Section 12(g)]https://www.sec.gov/Archives/edgar/data/1259942/000120621209000118/0001206212-09-000118-index.htm
2017-12-21DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1259942/000125994217000004/0001259942-17-000004-index.htm
2019-01-11DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1259942/000125994219000001/0001259942-19-000001-index.htm
2019-01-29D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1259942/000125994219000002/0001259942-19-000002-index.htm
2019-09-04CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1259942/000135445719000433/0001354457-19-000433-index.htm
2019-09-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1259942/000149315219014146/0001493152-19-014146-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1259942/000149315220002417/0001493152-20-002417-index.htm
2020-01-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1259942/999999999520000127/9999999995-20-000127-index.htm